Humans are Capable of Greatness | Capable

Capable

2 min read Original article ↗

HumansareCapableofGreatness

Capable turns frontier intelligence into frontier medicines.

Bulge Blur

Backed early with $12M by

Our Team

Helena
Rose

Isaak
Freeman

George
Church

Gregory
Bird

Melissa
Du

Nicolas
Pellier

Bradley
Pentelute

Stephen
Goldstein

Tristan
Dinsmore

Hillary
Allen

Luis
de Lecea

Moaraj
Hasan

Further backed by

Wojciech Zaremba

Srinivas Narayanan

Peter Diamandis

Kevin Weil

Julian Schrittwieser

Fidji Simo

Anne Lee Skates

Tyler Cowen

Stephen Malina

Elizabeth Weil

Anne Brandes

Michael Retchin

Rahul Arora

Will DePue

Philip Bogdanov

Justin Mares

Adam Draper

Gus Domel

Brayton Williams

Winnie Qiu

Amol Sarva

Inaki Berenguer

Trevor Chow

Michael Florea

Max Marchione

Larsen Jensen

Riley Loftus

Alexey Guzey

Andrej Karpathy

Context

In the age of ever-improving AI capabilities, we humans are lagging behind.

We're hungry, distractable, and tired.

Roughly half of us will get cancer or heart disease. We fall ill.

A third of our day is spent asleep.

The modern world feeds us slop that leads even further down the drain.

We believe that humans are capable of more.

Nature gave us clues on making this dream real. Research has given us insight into thousands of powerful rare variants.

We spend a third of our lives asleep. Yet, a small subset of humans thrive on four to six hours of sleep per night. They carry short sleeper variants, allowing them to remain healthy while being awake for longer. Previous research reports those short sleepers to have more energy, vigor, and disease resistance. While not definitive evidence, we see them as a proof-of-concept for our biggest frontier for improving human health.

Our first four programs are in sleep. Concretely, we are first working on therapeutics that restore cognitive performance under sleep deprivation, and then towards the end-goal of allowing patients to sleep 1-2 hours less. Our initial focus will be on rare, undertreated sleep diseases like narcolepsy and hypersomnia, while gradually expanding to a broader population, via shift-work sleep disorders.

Our Flagship Therapeutic

Our Flagship Therapeutic

The world's most successful drug is a peptide: In 2025, Tirzepatide made $36B.

What's the model that will design the next Tirzepatide?

We’re building a vertically integrated, AI-enabled, deeptech platform to rapidly explore and unlock new human capabilities.

Frontier models won’t be bottlenecked by intelligence. They’ll be bottlenecked by the speed of data and active learning.

Making peptide and nucleotide therapeutics rapidly with automated polymer synthesis.

Synthesis

Synthesis